MeSH D018088 - multidrug-resistant tuberculosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Mylan | Pretomanid | Dovprela (previously Pretomanid FGK) | 2020-07-31 | |||
| Johnson & Johnson | Bedaquiline | Sirturo | 2026-12-01 | 2012-12-28 | ||
| Otsuka | Delamanid | Deltyba | 2014-04-27 |
Clinical Trials
Historical Success Rate
Phase 1
100%4/4
Phase 2
67%16/24
Phase 3
57%13/23
Approved: 4Overall Success rate: 38%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use